Amneal Pharmaceuticals, Inc. (AMRX) stock rallied over 6.15% intraday to trade at $3.28 a share on NYSE. The stock opened with a gain of 7.19% at $3.15 and touched an intraday high of $3.31, rising 6.15% against the last close of $3.09. The stock went to a low of $3.11 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue2.09 Billion
5Y Sales Change20.50%
Fiscal Year Ends2021-12-30
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers Emverm, a chewable tablet for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; Rytary to treat Parkinson's disease; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) stock price is $3.28 as of the last check on Thursday, June 23. During the trading session, AMRX stock reached the peak price of $3.31 while $3.11 was the lowest point it dropped to.
The NYSE listed AMRX is part of Pharmaceuticals industry that operates in the broader Health Care sector. Amneal Pharmaceuticals, Inc. , together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas.
Mr. Chirag K. Patel
Co-Founder, Co-CEO, Pres & Director
Mr. Chintu Patel R.Ph, R.Ph.
Co-Founder, Co-CEO & Director
Mr. Anastasios G. Konidaris
Exec. VP & CFO
Ms. Nikita Shah
Exec. VP and Chief HR & Strategic Planning Officer
AMRX stock traded closed the last session at $3.28, which is $0.19 or 6.15% lower than its previous close of $3.09. AMRX's current trading price is 13.10% lower than its 52-week high of $5.99 where as its distance from 52-week low of 2.90% is -45.24%.
Number of AMRX employees currently stands at -. AMRX operates from 400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ 08807, United States.
Official Webiste of $AMRX is: https://www.amneal.com
AMRX stock volume for the day was 560,833 shares while in the previous session number of AMRX shares traded was 561,900 . The average number of AMRX shares traded daily for last 3 months was 756.07 Thousands.
The percentage change in AMRX stock occurred in the recent session was 6.15% while the dollar amount for the price change in AMRX stock was $0.19.
In the recent session, the day high for AMRX stock was $3.31 while the low for AMRX stock touched on the day was $3.11.
The market value of AMRX currently stands at 937.52 Million with its latest stock price at $3.28 and 149.89 Million of its shares outstanding.